Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease

被引:9
|
作者
Hisanaga, K
Suzuki, H
Tanji, H
Mochizuki, H
Iwasaki, Y
Sato, N
Jin, K
机构
[1] Miyagi Natl Hosp, Dept Neurol, Watarai, Miyagi 9892202, Japan
[2] Miyagi Natl Hosp, Dept Clin Res, Watarai, Miyagi 9892202, Japan
[3] Sendai Natl Hosp, Dept Pathol, Miyagino Ku, Sendai, Miyagi 9838520, Japan
[4] Tohoku Univ, Sch Med, Dept Neurol, Aoba Ku, Sendai, Miyagi 9808574, Japan
关键词
D O I
10.1007/s004150170079
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:905 / 906
页数:2
相关论文
共 50 条
  • [31] The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory
    Staffaroni, Adam M.
    Melrose, Rebecca J.
    Leskin, Lorraine P.
    Riskin-Jones, Hannah
    Harwood, Dylan
    Mandelkern, Mark
    Sultzer, David L.
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2017, 39 (07) : 682 - 693
  • [32] Transformation of myelodysplastic syndrome to acute myeloid leukemia: A case with whole-body 2-[F18] fluoro-2-deoxy-D-glucose positron emission tomography
    Liu, Fang
    Cao, Qinghua
    INDIAN JOURNAL OF NUCLEAR MEDICINE, 2011, 26 (02): : 104 - 106
  • [33] Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography (vol 94, e1978, 2015)
    Song, Y. S.
    Lee, W. W.
    Lee, J. S.
    MEDICINE, 2016, 95 (08)
  • [34] Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: Comparison with CT and PET
    Antoch, G
    Saoudi, N
    Kuehl, H
    Dahmen, G
    Mueller, SP
    Beyer, T
    Bockisch, A
    Debatin, JF
    Freudenberg, LS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (21) : 4357 - 4368
  • [35] Posterior scapular lymph nodes in a patient with follicular lymphoma on whole-body 2-deoxy-2-[18F]-fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT)
    Mahmood, S.
    de Liano, S. R. Martinez
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2008, 27 (03): : 202 - 203
  • [36] Clinical, fluorine-18 labeled 2-fluoro-2-deoxyglucose positron emission tomography (FDG PET), MRI of the brain and biochemical observations in a patient with 4-hydroxybutyric aciduria; a progressive neurometabolic disease
    Al-Essa, MA
    Bakheet, SM
    Patay, ZJ
    Powe, JE
    Ozand, PT
    BRAIN & DEVELOPMENT, 2000, 22 (02): : 127 - 131
  • [37] Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDC-PET) for accurate staging of Hodgkin's disease
    Bangerter, M
    Moog, F
    Buchmann, I
    Kotzerke, J
    Griesshammer, M
    Hafner, M
    Elsner, K
    Frickhofen, N
    Reske, SN
    Bergmann, L
    ANNALS OF ONCOLOGY, 1998, 9 (10) : 1117 - 1122
  • [38] Early whole body F18-FDG positron emission tomography (PET) restaging has significant prognostic impact in diffuse large cell lymphomas (DLCL-B) and other aggressive lymphomas.
    Trneny, M
    Jaeger, U
    Belohlavek, O
    Becherer, A
    Pytlik, R
    Skrabs, C
    BLOOD, 2002, 100 (11) : 768A - 768A
  • [39] Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker (CA-125 antigen)
    Chang, WC
    Hung, YC
    Kao, CH
    Yen, RF
    Shen, YY
    Lin, CC
    NEOPLASMA, 2002, 49 (05) : 329 - 333
  • [40] Prospective evaluation of 18F-fluorodeoxyglucose (FDG) positron emission tomography as a predictor of residual disease and subsequent relapse in patients with diffuse large cell ymphoma and Hodgkin's lymphoma undergoing HDC and ASCT
    Akhtar, S.
    Al-Sugair, A.
    Al Kadhi, Y.
    Al-Zahrani, A.
    Abdelsalam, M.
    Bazarbashi, S.
    Ajarim, D.
    Maghfoor, I.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S44 - S44